SPR Therapeutics Awarded $6 Million U.S. Department of Defense G

May 15th, 2017 | News
bioenterprise-2014

SPR Therapeutics, a Cleveland developer of medical devices, secured a $6 million grant from the U.S. Department of Defense. Funds will advance SPR’s SPRINT Peripheral Nerve Stimulation System for non-opioid relief of acute and chronic pain.

Read more here

Comments are closed.